New boss brings diagnostic edge to PEB

New boss brings diagnostic edge to PEB
Peter Meintjes has experience in the global molecular diagnostics sectors relevant to Pacific Edge’s Cxbladder products. (Image: Supplied)
Dan Brunskill
Pacific Edge has appointed a molecular diagnostics expert to lead the cancer diagnostics company after the retirement of long-serving chief executive David Darling.The new CEO, Peter Meintjes, has a PhD in biological sciences from Auckland University and has been chief commercial officer of US-based organ transplant testing company Eurofins Transplant Genomics.Prior to that he served as chief executive of Hungary-based Omixon, another global molecular diagnostics company focused on organ and recipient compatibility testing.Pacific Edge said whi...

More Markets

Trade Me parent company appoints Owen Wilson as director
Finance

Trade Me parent company appoints Owen Wilson as director

Wilson was CE of $A30b Australian digital-property company Rea Group Ltd.

Me Today’s $2.2m capital raise ‘exceeds expectations’
Markets

Me Today’s $2.2m capital raise ‘exceeds expectations’

The company’s two largest shareholders chipped in $1.5m.

Being AI’s bold plan: No business, still listed
Markets

Being AI’s bold plan: No business, still listed

From wannabe Google challenger to now selling off its last business to escape debt.

Westpac NZ eyes improved full-year 2026 profit on GDP gains
Finance

Westpac NZ eyes improved full-year 2026 profit on GDP gains

Looks to grow at pace of economy, invests in business.